Effect of a combined administration of aureomycin and nicotinic acid in ozena.
D001284:Atrophy; D002751:Chlortetracycline / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D009525:Niacin / Q000627:therapeutic use*; D009539:Nicotinic Acids; D012220:Rhinitis; D012222:Rhinitis, Atrophic / Q000628:therapy*; D012871:Skin Diseases
D009539:Nicotinic Acids; D009525:Niacin; D002751:Chlortetracycline
AUREOMYCIN/therapeutic use; NICOTINIC ACID/therapeutic use; RHINITIS, ATROPHIC/therapy